In the TCGA cohort, gliomas exhibiting elevated TNFRSF19 expression demonstrated a significantly higher TMB compared to gliomas with low TNFRSF19 expression, with statistical significance (P < 0.05, Fig. 6I). The gene discussed is TNFRSF19; the disease is glioma.